India’s pharmaceutical industry is growing fast, and there’s no slowing down. Experts believe it could double to around USD 130 billion by 2030.
Amid this booming sector, Asston Pharmaceuticals, a company that’s been active in the pharma space for years, is now launching its IPO. It is aiming to grow further and tap into the expanding opportunities.
The Asston Pharmaceuticals IPO lead manager is Sobhagya Capital Options and the registrar is Maashitla Securities.
Check the Asston Pharmaceuticals DRHP and RHP for more details.
Note: The lock-in period for 50% of Smarten Power Systems’ stock concludes 30 days post-allocation, whereas the remaining portion is released from lock-in after 90 days.
With focused planning and a solid team, Asston Pharmaceuticals Private Limited IPO is worth tracking. Check out its company highlights here.
Before you apply, take a quick look at what Asston Pharmaceuticals is all about. Check its Asston Pharmaceuticals IPO date price.
Here’s the schedule you’ll need for Asston Pharmaceuticals IPO process.
See the amount Asston Pharmaceuticals is planning to raise from its IPO.
The fund usage tells you a lot about their growth direction. Here’s how they plan to use their IPO proceeds.
Check the Asston Pharmaceuticals IPO price before you move forward with Asston Pharmaceuticals.
The bidding slots are divided as per investor type, and here’s how it works.
Get an active demat account to apply for the Asston Pharmaceuticals IPO. Click here to check out the top brokers!
Take a detailed look at how the company is performing financially.
Look at how profits and overall growth have shaped up for the business.
Strengths
The team works with WHO-GMP-certified partners to maintain product quality.
Products come in various forms. This makes it easy to meet global demand.
Outsourcing keeps the business light on assets and avoids big regulatory or setup costs.
Skilled staff across operations help meet quality checks at every stage.
Risks
If key talent leaves, it might affect growth and daily operations.
Pharma rules keep changing; missing an update could delay approvals.
Relying too much on a few customers can affect revenues if things shift.
No long-term contracts with manufacturers may affect future planning.
The Asston Pharmaceuticals IPO GMP of ₹10 suggests a listing price close to ₹133. Also, make sure you check the IPO schedule and pricing. You must check all the Asston Pharmaceuticals IPO details.
Submit your IPO bid for Asston Pharmaceuticals today.
1. What is the Asston Pharmaceuticals IPO date?
The Asston Pharmaceuticals IPO date is set for 09 July 2025. One can apply for shares on its starts date.
2. What is the Asston Pharmaceuticals IPO price?
The Asston Pharmaceuticals IPO share price is fixed in the range of ₹115 - ₹123 per equity share.
3. How can I apply for the Asston Pharmaceuticals IPO?
To apply, you will need an active Demat account. Applications can be submitted through your broker or via UPI-enabled platforms supported by your bank.
4. What is the Asston Pharmaceuticals IPO review?
The Asston Pharmaceuticals review from early market watchers highlights its presence in the pharmaceutical sector and potential for long-term value. However, it's advised to review the company’s financials, RHP, and past performance before investing.
5. Can retail investors participate in this IPO?
Retail investors can still apply for SME IPOs, but there’s a change. As per SEBI’s rule, the minimum application size is now ₹2 lakh. This means only those with higher investment capacity can participate in SME IPOs. It doesn't apply to mainboard IPOs, where smaller amounts are still allowed.
